These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7543954)

  • 1. [The effects of recombinant human granulocyte colony-stimulating factor on protracted neutropenia in patients with acute myelogenous leukemia. (rG.CSF Clinical Study Group)].
    Kimura Y; Toyama K; Hirashima K; Okuma M; Saito H; Ohno R; Ikeda Y; Tomonaga M; Asano S
    Rinsho Ketsueki; 1995 Jun; 36(6):589-96. PubMed ID: 7543954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A randomized controlled study of rG.CSF in patients with neutropenia after induction therapy for acute myelogenous leukemia. (rG.CSF Clinical Study Group)].
    Nakajima H; Ikeda Y; Hirashima K; Toyama K; Okuma M; Saito H; Ohno R; Tomonaga M; Asano S
    Rinsho Ketsueki; 1995 Jun; 36(6):597-605. PubMed ID: 7543955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A randomized double-blind controlled study of recombinant human granulocyte colony-stimulating factor in patients with neutropenia induced by consolidation chemotherapy for acute myeloid leukemia. (rG.CSF clinical study group)].
    Takeshita A; Ohno R; Hirashima K; Toyama K; Okuma M; Saito H; Ikeda Y; Tomonaga M; Asano S
    Rinsho Ketsueki; 1995 Jun; 36(6):606-14. PubMed ID: 7543956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia.
    Ohno R; Tomonaga M; Kobayashi T; Kanamaru A; Shirakawa S; Masaoka T; Omine M; Oh H; Nomura T; Sakai Y
    N Engl J Med; 1990 Sep; 323(13):871-7. PubMed ID: 1697646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hematological effect of 14 days treatment of recombinant human granulocyte colony-stimulating factor for neutropenia in myelodysplastic syndromes].
    Yoshida Y; Hirashima K; Asano S; Takaku F; Furusawa S; Ogawa T; Arimori S; Abe T; Suzuki T; Kato Y
    Rinsho Ketsueki; 1991 Jul; 32(7):743-50. PubMed ID: 1717726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of early administration of G-CSF after intensive chemotherapy in acute leukemia: a randomized controlled trial. Tokai Infection Study Group on Hematological Disorders].
    Takeyama H; Yamada H; Emi N; Saito H; Takeshita A; Ohno R; Yoshida H; Naoe T; Kageyama S; Shirakawa S
    Rinsho Ketsueki; 1995 Nov; 36(11):1257-65. PubMed ID: 8691565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
    Teshima H; Ishikawa J; Kitayama H; Yamagami T; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
    Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group.
    Ohno R; Tomonaga M; Ohshima T; Masaoka T; Asou N; Oh H; Nishikawa K; Kanamaru A; Murakami H; Furusawa S
    Int J Hematol; 1993 Aug; 58(1-2):73-81. PubMed ID: 7693029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on childhood neutropenias].
    Ueda K; Hanawa Y; Takaku F; Asano S; Tsukimoto I; Tsuchida M; Sato T; Ohira M; Hoshi Y; Nishihira K
    Rinsho Ketsueki; 1991 Mar; 32(3):212-20. PubMed ID: 1710294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
    Takeshita A; Saito H; Toyama K; Horiuchi A; Kuriya S; Furusawa S; Tsuruoka N; Takiguchi T; Matsuda T; Utsumi M; Shiku H; Matsui T; Egami K; Tamura K; Ohno R
    Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical study of recombinant human G-CSF in gynecological tumor patients with neutropenia due to chemotherapy (rG.CSF Clinical Study Group)].
    Terashima Y; Ochiai K; Hashimoto M; Nishiya I; Takamizawa H; Hasumi K; Takada M; Akiya K; Negishi Y; Takeda Y
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1461-71. PubMed ID: 1698901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose continuous subcutaneous infusion of granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in acute myelogenous leukemia and its pharmacokinetics.
    Ikeda K; Tasaka T; Sasaki K; Murata M; Kitanaka A; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1994 Nov; 8(11):1838-41. PubMed ID: 7526087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia.
    Hofmann WK; Seipelt G; Langenhan S; Reutzel R; Schott D; Schoeffski O; Illiger HJ; Hartmann F; Balleisen L; Franke A; Fiedler F; Huber C; Rasche H; Bergmann L; Ganser A; Pott C; Pasold R; Rudolph C; Ottmann OG; Gökbuget N; Hoelzer D
    Ann Hematol; 2002 Oct; 81(10):570-4. PubMed ID: 12424538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-macrophage colony stimulating factor treatment of febrile neutropenia following remission induction chemotherapy for acute leukemia.
    Cucuianu A; Petrov L; Ghiurt A; Vasilache A
    Rom J Intern Med; 1996; 34(1-2):97-103. PubMed ID: 8908636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor in acute myeloid leukemia.
    Usuki K; Iki S; Endo M; Kitazume K; Ito K; Watanabe M; Urabe A
    Stem Cells; 1995 Nov; 13(6):647-54. PubMed ID: 8590866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
    Dale DC; Cottle TE; Fier CJ; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Freedman MH; Kannourakis G; Kinsey SE; Davis R; Scarlata D; Schwinzer B; Zeidler C; Welte K
    Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia.
    Zhang WG; Wang FX; Chen YX; Cao XM; He AL; Liu J; Ma XR; Zhao WH; Liu SH; Wang JL
    Am J Hematol; 2008 Mar; 83(3):185-8. PubMed ID: 17899614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
    Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.